{
    "eid": "2-s2.0-85141893921",
    "title": "Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition",
    "cover-date": "2022-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Thareeya Phetphoung",
        "Ashwini Malla",
        "Kaewta Rattanapisit",
        "Nuttapat Pisuttinusart",
        "Naruechai Damrongyot",
        "Keerati Joyjamras",
        "Pithi Chanvorachote",
        "Tanapati Phakham",
        "Tossapon Wongtangprasert",
        "Richard Strasser",
        "Chatchai Chaotham",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 3,
    "ref-count": 76,
    "ref-list": [
        "Current Challenges in Cancer Treatment",
        "Cancer Immunotherapy, Part 1: Current Strategies and Agents",
        "Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System",
        "Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody",
        "Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer immunotherapy",
        "The blockade of immune checkpoints in cancer immunotherapy",
        "Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity",
        "PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy",
        "Immune checkpoint inhibitors of PD-L1 as cancer therapeutics",
        "The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors",
        "Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor",
        "Atezolizumab First-Line Combination Therapy: A Review in Metastatic Nonsquamous NSCLC",
        "Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors",
        "Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC",
        "Product review on the Anti-PD-L1 antibody atezolizumab",
        "Expression of recombinant antibodies",
        "Therapeutic recombinant protein production in plants: Challenges and opportunities",
        "Emerging antibody products and Nicotiana manufacturing",
        "Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants",
        "Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection",
        "Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2",
        "Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates",
        "Transgenic Plant-Produced Hydrolytic Enzymes and the Potential of Insect Gut-Derived Hydrolases for Biofuels",
        "Platforms for Plant-Based Protein Production",
        "Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity",
        "Plant-Produced Basic Fibroblast Growth Factor (bFGF) Promotes Cell Proliferation and Collagen Production",
        "Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana",
        "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis",
        "Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants",
        "Chapter 12\u2014SARS-CoV-2 vaccines: current trends and prospects of developing plant-derived vaccines",
        "Recombinant protein production in a variety of Nicotiana hosts: a comparative analysis",
        "Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production",
        "An Agrobacterium-mediated transient gene expression system for intact leaves",
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells",
        "PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?",
        "Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins",
        "Transgenic tea [Camellia sinensis (L.) O. Kuntze cv. Kangra Jat] plants obtained by Agrobacterium-mediated transformation of somatic embryos",
        "Improving agroinfiltration-based transient gene expression in Nicotiana benthamiana",
        "The protein N-glycosylation in plants",
        "Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure",
        "Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)fucose residues",
        "Fc glycans of therapeutic antibodies as critical quality attributes",
        "Regulatory approval and a first-inhuman phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants",
        "Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and \u226550 years old adults",
        "Anoikis resistance and tumor metastasis",
        "Anoikis",
        "Anoikis resistance: an essential prerequisite for tumor metastasis",
        "Anoikis molecular pathways and its role in cancer progression",
        "Anoikis: an emerging hallmark in health and diseases",
        "The intracellular signalosome of PD-L1 in cancer cells",
        "Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy",
        "Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)",
        "Renieramycin M Sensitizes Anoikis-resistant H460 Lung Cancer Cells to Anoikis",
        "Jorunnamycin A from Xestospongia sp. Suppresses Epithelial to Mesenchymal Transition and Sensitizes Anoikis in Human Lung Cancer Cells",
        "Avicequinone B sensitizes anoikis in human lung cancer cells",
        "Quantification of Pharmacokinetic Profiles of PD-1/PD-L1 Antibodies by Validated ELISAs",
        "Targeting MCL-1 in cancer: current status and perspectives",
        "Mcl-1 is required for melanoma cell resistance to anoikis",
        "ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis",
        "Bcl-2 and caspase-8 related anoikis resistance in human osteosarcoma MG-63 cells",
        "The basics of epithelial-mesenchymal transition",
        "Cadherin Switch in Tumor Progression",
        "N-Cadherin-mediated Intercellular Interactions Promote Survival and Migration of Melanoma Cells",
        "The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells",
        "The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion",
        "A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis",
        "Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes",
        "A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition",
        "Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion",
        "The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200",
        "Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells",
        "The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects",
        "The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer",
        "Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199584",
            "affilname": "Chulalongkorn Cancer Immunotherapy Excellence Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199584",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60024895",
            "affilname": "Universitat fur Bodenkultur Wien",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024895",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "128663406",
            "affilname": "Ltd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128663406",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Graduate School and Faculty of Pharmaceutical Sciences",
        "Chulalongkorn University",
        "National Research Council of Thailand"
    ]
}